SCHEMBL25668530

SCHEMBL25668530

c1ccc(-c2nc(-c3cccc4c(-c5ccccc5)cccc34)nc(-c3cccc4c(-c5cccc6ccccc56)cccc34)n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.56
▸ SMN1; SMN2 Q16637 4/20 0.56
▸ KDM4E B2RXH2 4/20 0.56
▸ ALDH1A1 P00352 4/20 0.56
▸ HPGD P15428 4/20 0.56
▸ TSHR P16473 2/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ HSD17B10 Q99714 2/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ TP53 P04637 1/20 0.56
▸ NFKB1 P19838 1/20 0.56
▸ NFKB2 Q00653 1/20 0.56
▸ RELA Q04206 1/20 0.56
▸ ATM Q13315 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ TNF P01375 1/20 0.51
▸ HDAC8 Q9BY41 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.45
▸ ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25668538 0.98 MAPT (0.54) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL25668527 0.98 MAPT (0.54) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL27456041 0.98 MAPT (0.54) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL27129092 0.96 MAPT (0.53) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL25668561 0.96 MAPT (0.53) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23633622 0.96 MAPT (0.56) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL27455675 0.96 MAPT (0.56) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL24582816 0.96 MAPT (0.56) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL25668514 0.96 MAPT (0.59) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL25668518 0.96 MAPT (0.59) MAPTSMN1; SMN2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147959-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 MAPT 958/4885SMN1; SMN2 4181/4885KDM4E 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback